EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic Insights into and In Vitro Evaluation of Antimicrobial Combination Therapies for Carbapenem-Resistant Acinetobacter baumannii

Saadia Ijaz, Farheen Ansari, Muhammad Nawaz iD, Hasan Ejaz iD, Aftab Ahmad Anjum iD, Aqib Saeed, Tehreem Ali iD, Obaid Ur Rehman, Eeshal Fatima iD, Tayyaba Ijaz

Medicina · 2024

DOI: 10.3390/medicina60071086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina, 2024. Verfasst von Saadia Ijaz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology & Biotechnology (IMBB), University of Lahore, Lahore 54590, Pakistan. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Carbapenems, Microbial Sensitivity Tests, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Acinetobacter baumannii (A. baumannii), particularly carbapenem-resistant A. baumannii (CRAB), represents a grave concern in healthcare settings and is associated with high mortality. This study aimed to conduct molecular, mutational, and phylogenetic analyses of specific genes in CRAB and evaluate the synergistic effects of selected antimicrobial combinations. Materials and Methods: Phenotypic characterization was performed on six CRAB strains by using the Modified Hodge Test (MHT) and IMP-EDTA Double-Disc Synergy Test (IMP-EDTA DDST). Carbapenemase- and metallo-beta-lactamase-encoding genes were amplified by using Polymerase Chain Reaction. Phylogenetic analysis using the MEGA 11 tool was used to determine the evolutionary relatedness of these genes. Mutational analysis was performed by using I-Mutant, MUPro, and PHD-SNP bioinformatics tools to predict mutations in the carbapenemase-encoding genes. Microdilution checkerboard titration assessed the synergistic effects of antimicrobial combinations (azithromycin–meropenem, rifampicin–meropenem, meropenem–colistin, and azithromycin–colistin) on these CRAB isolates.

Results

The phenotypic characterization of six CRAB isolates revealed positive results for MHT and IMP-EDTA DDST. The molecular characterization revealed that carbapenemase- and MBL-encoding genes were present in all isolates with varying frequencies, including blaOXA-51 (100%) and blaIMP (0%). The sequence analysis revealed high evolutionary relatedness to sequences in the NCBI database. The mutational analysis identified 16 mutations, of which 1 mutation (P116L) in the blaOXA-58 gene predicted a change in the protein product, potentially contributing to carbapenem resistance. The checkerboard titration method did not reveal any synergism among the tested antimicrobial combinations against CRAB.

Conclusion

This study’s findings underscore the significant challenges posed by CRAB isolates harboring multiple resistant genes in treatment. This highlights the urgent need for novel antimicrobial agents, a crucial step towards reducing mortality rates not only in Pakistan but also globally.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiCarbapenemsMicrobial Sensitivity TestsAnti-Bacterial AgentsHumansbeta-LactamasesAcinetobacter InfectionsBacterial ProteinsDrug Therapy, CombinationPhylogeny

Stichwörter der Autor:innen

A. baumanniicarbapenem resistancecheckerboard method

Substanzen

CarbapenemsAnti-Bacterial Agentsbeta-LactamasesBacterial Proteinscarbapenemase

Autor:innen und Institutionen

  • Institute of Molecular Biology & Biotechnology (IMBB), University of Lahore, Lahore 54590, Pakistan.
  • Institute of Microbiology, University of Veterinary and Animal Sciences, Lahore 54000, Pakistan.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia.
  • Department of Medicine, Services Institute of Medical Sciences, Lahore 54000, Pakistan.
  • Mayo Hospital, Health Department, Lahore 54000, Pakistan.

ORCID-Profile: Muhammad Nawaz, Hasan Ejaz, Aftab Ahmad Anjum, Tehreem Ali, Eeshal Fatima

Zitieren

APA

Ijaz, S., Ansari, F., Nawaz, M., Ejaz, H., Anjum, A. A., Saeed, A., Ali, T., Rehman, O. U., Fatima, E., & Ijaz, T. (2024). Genomic Insights into and In Vitro Evaluation of Antimicrobial Combination Therapies for Carbapenem-Resistant Acinetobacter baumannii. Medicina. https://doi.org/10.3390/medicina60071086

Vancouver

Ijaz S, Ansari F, Nawaz M, Ejaz H, Anjum AA, Saeed A, et al. Genomic Insights into and In Vitro Evaluation of Antimicrobial Combination Therapies for Carbapenem-Resistant Acinetobacter baumannii. Medicina. 2024. doi:10.3390/medicina60071086

BibTeX
@article{Ijaz2024,
  author = {Ijaz, Saadia and Ansari, Farheen and Nawaz, Muhammad and Ejaz, Hasan and Anjum, Aftab Ahmad and Saeed, Aqib and Ali, Tehreem and Rehman, Obaid Ur and Fatima, Eeshal and Ijaz, Tayyaba},
  title = {Genomic Insights into and In Vitro Evaluation of Antimicrobial Combination Therapies for Carbapenem-Resistant Acinetobacter baumannii},
  journal = {Medicina},
  year = {2024},
  doi = {10.3390/medicina60071086}
}
Kostenlos starten →